advertisement
11.14 Investigational drugs; pharmacological experiments (30)
Showing records 1 to 25
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments28116 Cationic nano-copolymers mediated IKK(beta) targeting siRNA to modulate wound healing in a monkey model of glaucoma filtration surgery
Ye H; Qian Y; Lin M; Duan Y; Sun X; Zhuo Y; Ge J
Molecular Vision 2010; 16: 2502-2510
27917 The effect of biophysical attributes of the ocular trabecular meshwork associated with glaucoma on the cell response to therapeutic agents
McKee CT; Wood JA; Shah NM; Fischer ME; Reilly CM; Murphy CJ; Russell P
Biomaterials 2011; 32: 2417-2423
27850 Endothelin antagonism as an active principle for glaucoma therapy
Rosenthal R; Fromm M
British Journal of Pharmacology 2011; 162: 806-816
27706 Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats
Huang TL; Chang CH; Lin KH; Sheu MM; Tsai RK
Experimental Eye Research 2011; 92: 112-119
27688 Efficacy of tetrandrine on lowering intraocular pressure in animal model with ocular hypertension
Huang P; Xu Y; Wei R; Li H; Tang Y; Liu J; Zhang SS; Zhang C
Journal of Glaucoma 2011; 20: 183-188
27676 Alpha-Crystallin Promotes Rat Retinal Neurite Growth on Myelin Substrates in vitro
Wang YH; Wang DW; Wu N; Wang Y; Yin ZQ
Ophthalmic Research 2010; 45: 164-168
27958 Effect of SPP 301, an endothelin antagonist, on intraocular pressure in glaucomatous monkey eyes
Wang R-F; Podos SM; Serle JB; Baltatu OC
Current Eye Research 2011; 36: 41-46
27741 Cytokine-Dependent ELAM-1 Induction and Concomitant Intraocular Pressure Regulation in Porcine Anterior Eye Perfusion Culture
Birke MT; Birke K; Lütjen-Drecoll E; Schlötzer-Schrehardt U; Hammer CH
Investigative Ophthalmology and Visual Science 2011; 52: 468-475
27960 Effect of avosentan (SPP-301) in porcine ciliary arteries
Konieczka K; Meyer P; Schoetzau A; Neutzner A; Mozaffarieh M; Flammer J
Current Eye Research 2011; 36: 118-124
28157 Management of chronic anterior uveitis relapses: Efficacy of oral phospholipidic curcumin treatment. Long-term follow-up
Allegri P; Mastromarino A; Neri P
Clinical Ophthalmology 2010; 4: 1201-1206
28205 Pharmacotherapies for glaucoma
Toris CB
Current Molecular Medicine 2010; 10: 824-840
28149 Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
Pozarowska D
Clinical Ophthalmology 2010; 4: 1229-1236
28150 Diurnal IOP-lowering efficacy and safety of travoprost 0.004% compared with tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertension
Schnober D; Hofmann G; Maier H; Scherzer M-L; Ogundele AB; Jasek MC
Clinical Ophthalmology 2010; 4: 1459-1463
27999 Similarities and differences between primary and secondary degeneration of the optic nerve and the effect of minocycline
Levkovitch-Verbin H; Spierer O; Vander S; Dardik R
Graefe's Archive for Clinical and Experimental Ophthalmology 2011; 1-9
28068 Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma
Colafrancesco V; Parisi V; Sposato V; Rossi S; Russo MA; Coassin M; Lambiase A; Aloe L
Journal of Glaucoma 2011; 20: 100-108
27938 Secretoneurin and the tachykinins substance P and neurokinin-A/B in NMDA-induced excitotoxicity in the rat retina
Teuchner B; Dimmer A; Troger J; Fischer-Colbrie R; Schmid E; Kieselbach G; Dietrich H; Bechrakis N
Regulatory Peptides 2010; 165: 123-127
28019 Neuroprotective effect of PACAP against NMDA-induced retinal damage in the mouse
Endo K; Nakamachi T; Seki T; Kagami N; Wada Y; Nakamura K; Kishimoto K; Hori M; Tsuchikawa D; Shinntani N
Journal of Molecular Neuroscience 2011; 43: 22-29
28048 Neuro-protective effects of yiyanming solution on visual function of glaucoma patient
Wang Y; Qiu B; Zhang C-X; Ou Y; Pang L; Li Z-P
Chinese Ophthalmic Research 2010; 28: 1087-1090
28035 Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitors
Fang X; Chen YT; Sessions EH; Chowdhury S; Vojkovsky T; Yin Y; Pocas JR; Grant W; Schroter T; Lin L
Bioorganic and Medicinal Chemistry Letters 2011; 21:1844-1848
28165 Use of calcium channel blockers for glaucoma
Araie M; Mayama C
Progress in Retinal and Eye Research 2011; 30: 54-71
27758 Quercetin Induces the Expression of Peroxiredoxins 3 and 5 via the Nrf2/NRF1 Transcription Pathway
Miyamoto N; Izumi H; Miyamoto R; Kondo H; Tawara A; Sasaguri Y; Kohno K
Investigative Ophthalmology and Visual Science 2011; 52: 1055-1063
28181 Emerging drugs for ocular hypertension
Lee AJ; Goldberg I
Expert Opinion on Emerging Drugs 2011; 16: 137-161
28222 Role of nitric oxide in the regulation of intraocular pressure: A possibility for glaucoma treatment
Vapaatalo H; Kotikoski H; Oksala O
Expert Review of Ophthalmology 2010; 5: 751-758
28185 Future possibilities in glaucoma therapy
Wierzbowska J; Robaszkiewicz J; Figurska M; Stankiewicz A
Case Reports and Clinical Practice Review 2010; 16: 252-259
27737 Effects of Fasudil, a Rho-Associated Protein Kinase Inhibitor, on Optic Nerve Head Blood Flow in Rabbits
Sugiyama T; Shibata M; Kajiura S; Okuno T; Tonari M; Oku H; IkedaT
Investigative Ophthalmology and Visual Science 2011; 52: 64-69